A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 7 (2), 75-81
- https://doi.org/10.3109/09546639609089533
Abstract
In slow-healing wounds, i.e. those with little granulation tissue with deep necrotic tissue and exudation, complicated by inflammation, there is depolymerization and degradation of local mucopolysaccharides, especially hyaluronic acid. A local deficit of hyaluronic acid leads to insufficient regeneration of connective tissue, poor angiogenesis and deficient differentiation of histiocyte and fibroblast populations. Exogenous hyaluronic acid applied to a debrided wound keeps it moist and ensures a high concentration at the site of action. Hyaluronic acid stabilizes the clot matrix, attracts inflammatory, mesenchymal and epithelial cells into the wound area and enhances angiogenesis of the clot tissue. It also exerts an antiexudative, vasoprotective and fibrogenic action in inflamed tissues of slow-healing wounds. In this multicentre controlled study we evaluated the efficacy and safety of hyaluronic acid in 50 patients with venous leg ulcers in comparison with Dextranomer, the product of choice for this indication in France. Objective parameters, including the appearance and dimensions of the ulcer, improved significantly in both treatment groups. However, there was a faster and greater reduction in the ulcer dimensions following treatment with hyaluronic acid. Both treatments improved surrounding erythema, pain, oozing and necrosis but only hyaluronic acid caused a significant decrease in oedema. A greater number of positive efficacy judgements were seen in the hyaluronic acid group. The local tolerability of the two treatments was excellent. Hyaluronic acid is therefore a safe and effective treatment for patients with venous leg ulcers.Keywords
This publication has 14 references indexed in Scilit:
- Characterization of macrophages elicited by intraperitoneal injection of hyaluronateInflammation Research, 1986
- A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healingJournal of Theoretical Biology, 1986
- Angiogenesis Induced by Degradation Products of Hyaluronic AcidScience, 1985
- Hyaluronic acid enhances phagocytosis of human monocytesin vitroJournal of Clinical Immunology, 1984
- Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism.JCI Insight, 1980
- Physiological function of connective tissue polysaccharides.Physiological Reviews, 1978
- Local Wound Environment and Epidermal HealingArchives of Dermatology, 1972
- The extracellular matrix of the regenerating newt limb: Synthesis and removal of hyaluronate prior to differentiationDevelopmental Biology, 1971
- THE REGULATION OF PINOCYTOSIS IN MOUSE MACROPHAGESThe Journal of Experimental Medicine, 1967
- Effect of Air Drying and Dressings on the Surface of a WoundNature, 1963